Zdrowie i gospodarka · 11/07/2000
FDA Publishes Notice on Exemption Petition for Triiodothyronine Test System
The FDA is seeking public comments on a petition to exempt the total triiodothyronine test system, a Class II device, from premarket notification requirements, as mandated by the Food and Drug Administration Modernization Act of 1997.
Source: Federal Register — Food and Drug AdministrationOpen original release →